CORAL LABORATORIES LTD. Share Price
CORAL LABORATORIES LTD. Returns Calculator
About CORAL LABORATORIES LTD.
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
CORAL LABORATORIES LTD. Financial Highlights
- Revenue: CORAL LABORATORIES LTD. reported revenue of ₹95.80 crore in FY26 vs ₹124.12 crore in FY25. It showed a decrease of 22.82% on a yearly basis.
- Operating Profit: CORAL LABORATORIES LTD. reported an operating profit of ₹23.11 crore in FY26 vs ₹32.47 crore in FY25. It showed a decrease of 28.83% on a year-on-year basis.
- Net Profit: CORAL LABORATORIES LTD. reported a net profit of ₹16.38 crore in FY26 vs ₹24.16 crore in FY25. It showed a decrease of 32.20% on a yearly basis.
CORAL LABORATORIES LTD. Quarterly Result Highlights
- CORAL LABORATORIES LTD. reported revenue of ₹29.13 crore in Mar 2026, compared with ₹24.05 crore in Dec 2025, representing an increase of 21.12% on a quarter-on-quarter (QoQ) basis.
- CORAL LABORATORIES LTD. reported an operating profit of ₹8.29 crore in Mar 2026, compared with ₹3.70 crore in Dec 2025, representing an increase of 124.05% on a quarter-on-quarter (QoQ) basis.
- CORAL LABORATORIES LTD. reported a profit of ₹5.22 crore in Mar 2026, compared with ₹2.78 crore in Dec 2025, reflecting an increase of 87.77% on a QoQ basis.
- The earnings per share (EPS) of CORAL LABORATORIES LTD. stood at ₹67.61 during Mar 2026.
| Sep 2025 | 0.00% |
|---|---|
| Dec 2025 | 0.00% |
| Mar 2026 | 0.00% |
| Jun 2026 | 0.00% |
CORAL LABORATORIES LTD. Shareholder Returns
CORAL LABORATORIES LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,67,630.00 | 38.59 | 5.60 | 13.74% | 0.61 | 17.33% | 93.24 | 0.82% | 0.48 | 10.90 |
| Divis Laboratories | 2,18,972.00 | 74.86 | 13.06 | 15.32% | 0.00 | 19.56% | 629.49 | 0.36% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,88,358.00 | 87.37 | 22.40 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Cipla | 1,18,915.00 | 35.44 | 3.45 | 11.27% | 0.00 | 14.95% | 423.36 | 0.88% | 0.45 | 43.52 |
| Zydus Lifesciences | 1,11,242.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,07,907.00 | 19.44 | 4.81 | 23.76% | 0.04 | 24.88% | 659.05 | 0.76% | 0.57 | 129.18 |
| Mankind Pharma | 1,00,730.00 | 48.72 | 6.18 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Laurus Labs | 1,00,228.00 | 91.92 | 18.91 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Dr. Reddy's Laboratories | 97,824.00 | 30.73 | 2.57 | 11.07% | 0.18 | 12.54% | 377.96 | 0.68% | 0.41 | 38.68 |
| Aurobindo Pharma | 96,471.10 | 26.00 | 2.55 | 9.25% | 0.19 | 11.76% | 391.14 | 0.24% | 0.38 | 41.58 |
CORAL LABORATORIES LTD. Financials
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹115.01 | ₹83.66 | ₹78.12 | ₹75.61 |
| Other Income | ₹9.11 | ₹6.63 | ₹6.90 | ₹4.81 |
| Total Revenue | ₹124.11 | ₹90.29 | ₹85.01 | ₹80.42 |
| Total Expenses | ₹90.87 | ₹69.40 | ₹76.83 | ₹69.53 |
| Profit Before Tax | ₹32.47 | ₹20.73 | ₹8.23 | ₹11.86 |
| Tax | ₹8.31 | ₹4.94 | ₹1.78 | ₹2.81 |
| Profit After Tax | ₹24.16 | ₹15.79 | ₹6.45 | ₹9.05 |
| EPS - Basic | ₹67.61 | ₹44.19 | ₹18.04 | ₹25.32 |
| EPS - Diluted | ₹67.61 | ₹44.19 | ₹18.04 | ₹25.32 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹33.24 | ₹20.90 | ₹8.19 | ₹10.90 |
| Income before WC changes | ₹30.23 | ₹18.93 | ₹8.57 | ₹10.89 |
| Change in Assets | -₹17.23 | -₹25.02 | ₹13.35 | -₹3.37 |
| Change in Liabilities | -₹6.89 | ₹5.51 | -₹7.29 | ₹2.93 |
| Change in WC | -₹24.12 | -₹19.51 | ₹6.06 | -₹0.44 |
| Cash flow from Operations | -₹1.22 | -₹5.46 | ₹12.67 | ₹6.08 |
| Cash flow from Investing | -₹0.15 | ₹1.40 | -₹2.61 | -₹6.05 |
| Cash flow from Financing | ₹2.71 | ₹0.01 | -₹6.43 | ₹0.15 |
| Total Cash Flow | ₹1.33 | -₹4.06 | ₹3.62 | ₹0.18 |
| Cash (Start of the year) | ₹2.07 | ₹6.13 | ₹2.51 | ₹2.32 |
| Cash (End of the year) | ₹3.41 | ₹2.07 | ₹6.13 | ₹2.51 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹52.92 | ₹51.83 | ₹50.81 | ₹59.09 |
| Current Assets | ₹176.55 | ₹153.85 | ₹123.54 | ₹130.80 |
| Total Assets | ₹229.46 | ₹205.68 | ₹174.35 | ₹189.90 |
| Current Liabilities | ₹24.96 | ₹24.90 | ₹11.86 | ₹25.52 |
| Net Current Asset | ₹151.59 | ₹128.96 | ₹111.68 | ₹105.29 |
| Non-Current Liabilities | ₹3.30 | ₹3.28 | ₹7.69 | ₹8.33 |
| Equity Capital | ₹201.21 | ₹177.50 | ₹154.80 | ₹156.05 |
| Total Equity & Liabilities | ₹229.46 | ₹205.68 | ₹174.35 | ₹189.90 |
| 7 Aug | 0L |
|---|---|
| 6 Aug | 0L |
| 5 Aug | 0L |
| 4 Aug | 0L |
| 3 Aug | 0L |
| Average | 0L |
Popular Stocks
CORAL LABORATORIES LTD. Share Price FAQs
What is CORAL LABORATORIES LTD. share price today?
CORAL LABORATORIES LTD. share price is ₹577.85 as on 07 Aug, 2026, 15:08 IST.
How has the CORAL LABORATORIES LTD. share price performed in the past?
In the last 1 year, CORAL LABORATORIES LTD. delivered a return of 0.69%. The CORAL LABORATORIES LTD. share price hit a high of ₹659.00 and low of ₹360.00.
How much is the Mutual Fund shareholding in CORAL LABORATORIES LTD. shares?
The Mutual Fund Shareholding in CORAL LABORATORIES LTD. was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of CORAL LABORATORIES LTD. shares ?
The 52-week high and low of CORAL LABORATORIES LTD. share is ₹659.00 and ₹360.00 as of 07 Aug, 2026.
What is the market cap of CORAL LABORATORIES LTD.?
The market capitalisation of CORAL LABORATORIES LTD. is ₹206.31 Crores as on 07 Aug, 2026.
What are the stock symbols of CORAL LABORATORIES LTD.?
The stock symbol of CORAL LABORATORIES LTD. is 524506 on the BSE, and the ISIN is INE683E01017.
What was yesterday's closing price for CORAL LABORATORIES LTD. shares ?
CORAL LABORATORIES LTD. shares closed yesterday at ₹577.90 on BSE
How to buy CORAL LABORATORIES LTD. shares?
To buy CORAL LABORATORIES LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy CORAL LABORATORIES LTD. shares on Holidays?
No, shares of CORAL LABORATORIES LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell CORAL LABORATORIES LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of CORAL LABORATORIES LTD.?
The PE and PB ratio of CORAL LABORATORIES LTD. is 12.59 and 0.99 respectively, as on 07 Aug, 2026, 15:08 IST.